Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An integrated molecular risk score early in life for subsequent childhood asthma risk.
Böck A, Urner K, Eckert JK, Salvermoser M, Laubhahn K, Kunze S, Kumbrink J, Hoeppner MP, Kalkbrenner K, Kreimeier S, Beyer K, Hamelmann E, Kabesch M, Depner M, Hansen G, Riedler J, Roponen M, Schmausser-Hechfellner E, Barnig C, Divaret-Chauveau A, Karvonen AM, Pekkanen J, Frei R, Roduit C, Lauener R, Schaub B; CHAMP study group; PASTURE study group. Böck A, et al. Among authors: hamelmann e. Clin Exp Allergy. 2024 May;54(5):314-328. doi: 10.1111/cea.14475. Epub 2024 Mar 31. Clin Exp Allergy. 2024. PMID: 38556721 Free article.
CHildhood Allergy and tolerance: Biomarkers and Predictors (CHAMP) and quality of life.
Eckert JK, Kahle J, Böck A, Zeber K, Urner K, Greiner W, Kreimeier S, Beyer K, Dobbertin-Welsch J, Hamelmann E, Gellhaus I, Schorlemer C, Kabesch M, Kheiroddin P, von Mutius E, Depner M, Walter D, Hansen G, DeStefano S, Schnadt S, Schaub B; CHAMP Consortium. Eckert JK, et al. Among authors: hamelmann e. Pediatr Allergy Immunol. 2022 Jan;33(1):e13652. doi: 10.1111/pai.13652. Epub 2021 Aug 30. Pediatr Allergy Immunol. 2022. PMID: 34396594 No abstract available.
Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.
Blumchen K, Beder A, Beschorner J, Ahrens F, Gruebl A, Hamelmann E, Hansen G, Heinzmann A, Nemat K, Niggemann B, Wahn U, Beyer K. Blumchen K, et al. Among authors: hamelmann e. J Allergy Clin Immunol. 2014 Aug;134(2):390-8. doi: 10.1016/j.jaci.2014.03.035. Epub 2014 May 13. J Allergy Clin Immunol. 2014. PMID: 24831438 Clinical Trial.
Early priming of asthma and respiratory allergies: Future aspects of prevention: A statement by the European Forum for Education and Research in Allergy and Airway Disease (EUFOREA) and the EAACI-Clemens von Pirquet Foundation.
Wahn U, Lau S, Eigenmann P, Melen E, Krauss-Etschmann S, Lex C, Matricardi P, Schaub B, Halken S, Ege M, Jackson D, Hamelmann E, Szépfalusi Z, Garcia AN, von Mutius E. Wahn U, et al. Among authors: hamelmann e. Pediatr Allergy Immunol. 2022 Apr;33(4):e13773. doi: 10.1111/pai.13773. Pediatr Allergy Immunol. 2022. PMID: 35470937
Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy.
Blumchen K, Trendelenburg V, Ahrens F, Gruebl A, Hamelmann E, Hansen G, Heinzmann A, Nemat K, Holzhauser T, Roeder M, Rosenfeld L, Hartmann O, Niggemann B, Beyer K. Blumchen K, et al. Among authors: hamelmann e. J Allergy Clin Immunol Pract. 2019 Feb;7(2):479-491.e10. doi: 10.1016/j.jaip.2018.10.048. Epub 2018 Nov 10. J Allergy Clin Immunol Pract. 2019. PMID: 30423449 Clinical Trial.
Primary prevention of allergy: avoiding risk or providing protection?
Hamelmann E, Beyer K, Gruber C, Lau S, Matricardi PM, Nickel R, Niggemann B, Wahn U. Hamelmann E, et al. Clin Exp Allergy. 2008 Feb;38(2):233-45. doi: 10.1111/j.1365-2222.2007.02901.x. Epub 2007 Dec 12. Clin Exp Allergy. 2008. PMID: 18081883 Review.
294 results